REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • April 28th, 2023 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances
This REGISTRATION RIGHTS AGREEMENT (this “Agreement”), dated as of April 26, 2023, is by and between Keystone Capital Partners, LLC, a Delaware limited liability company (the “Investor”), and Navidea Biopharmaceuticals, Inc., a Delaware corporation (the “Company”).
COMMON STOCK PURCHASE AGREEMENT Dated as of April 26, 2023 by and among NAVIDEA BIOPHARMACEUTICALS, INC., and KEYSTONE CAPITAL PARTNERS, LLCCommon Stock Purchase Agreement • April 28th, 2023 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances • New York
This COMMON STOCK PURCHASE AGREEMENT is made and entered into as of April 26, 2023 (this “Agreement”), by and among Keystone Capital Partners, LLC, a Delaware limited liability company (the “Investor”), Navidea Biopharmaceuticals, Inc., a Delaware corporation (the “Company”).
SECURED BRIDGE NOTESecured Bridge Note • April 28th, 2023 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances
For Value Received, Navidea Biopharmaceuticals, Inc., a Delaware corporation with an address of 4995 Bradenton Ave #240, Dublin, OH 43017, (the “Borrower”) hereby promises to pay to the order of John K. Scott, Jr., an individual (the “Lender”) in the lawful money of the United States of America, at such place as Lender may from time to time designate the original principal sum of Three Hundred Thousand and 00/100 Dollars ($300,000.00) or, if less, the aggregate principal amount of all advances made by the Lender to the Borrower. This Secured Bridge Note (the “Note”) evidences advances made by the Lender to the Borrower.
FIRST AMENDMENT TO SECURITY AGREEMENTSecurity Agreement • April 28th, 2023 • Navidea Biopharmaceuticals, Inc. • In vitro & in vivo diagnostic substances
THIS FIRST AMENDMENT TO SECURITY AGREEMENT (this "Amendment"), dated as of April 25, 2023, is made by and between Navidea Biopharmaceuticals, Inc., a Delaware corporation with an address of 4995 Bradenton Ave #240, Dublin, OH 43017 (“Debtor”) and John Kim Scott Jr., an individual (“Secured Party”).
